Ann: Penthrox Licensing Deal for Russia, page-3

Some way off first sales though. Clinical trials, reg process etc to be completed etc. all costs borne by this new distribution partner.
what I am having trouble getting my head around is that this company like others are picking up all or most of the upfront approval costs. Now I don't think they're doing that for zero. The margins for MVP must be squeezed considerably. I am guessing. Would like someone to explain how this works.
When it comes to distribution these guys drive hard bargains unless there's competitive tension.